General Announcement::NOTICE TO HOLDERS OF THE REDEMPTION OF US$182,500,000

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
20-Nov-2020 20:19:30
Status
New
Announcement Sub Title
NOTICE TO HOLDERS OF THE REDEMPTION OF US$182,500,000
Announcement Reference
SG201120OTHROUDH
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
20/11/2020 17:30:00
Description (Please provide a detailed description of the event in the box below)
NOTICE TO HOLDERS OF THE REDEMPTION OF US$182,500,000 AGGREGATE PRINCIPAL AMOUNT OF THE
4.5% SENIOR NOTES DUE 2021 OF GLENMARK PHARMACEUTICALS LIMITED

Attachments

Redemption Notice.pdf
Total size =1623K